On the Bleeding Edge: Mastering GI Emergencies and Inpatient GI Consultation (On-Demand) | 2026-12 - Rajvanshi Liver Pearls that Change In Patient Management

Pdf Summary

This presentation highlighted practical “pearls” that can change inpatient liver care:

- <strong>Acute liver failure vs. acute-on-chronic liver failure:</strong> New encephalopathy with INR ≥1.5 and no known liver disease should be treated as <strong>acute liver failure until proven otherwise</strong>, with early transplant-center contact.  
- <strong>N-acetylcysteine (NAC):</strong> Beyond acetaminophen toxicity, NAC improves transplant-free survival in <strong>early non-APAP acute liver failure</strong> and can reduce short-term mortality when added to <strong>prednisolone in severe alcohol-associated hepatitis</strong>.  
- <strong>Transplant referral:</strong> Patients with cirrhosis should be referred at <strong>first decompensation</strong> (especially ascites) or around <strong>MELD 12</strong>, not only when MELD is high.  
- <strong>SBP prophylaxis:</strong> Primary prophylaxis should be limited to <strong>high-risk</strong> patients with low-protein ascites plus advanced liver or renal dysfunction.  
- <strong>Albumin:</strong> Use albumin for <strong>SBP</strong>, <strong>large-volume paracentesis</strong>, and selected <strong>HRS-AKI</strong> cases—not for routine non-SBP infections or to correct serum albumin.  
- <strong>CSPH:</strong> Clinically significant portal hypertension can be diagnosed by imaging/elastography or clinical surrogates; <strong>carvedilol</strong> can prevent first decompensation even if EGD shows no varices.  
- <strong>HRS-AKI:</strong> <strong>Norepinephrine + albumin</strong> is preferred over midodrine/octreotide strategies.  
- <strong>Variceal bleeding/coagulopathy:</strong> INR is misleading; check <strong>fibrinogen</strong> early and replace low levels with cryoprecipitate. Avoid reflexive FFP.  
- <strong>Platelet management:</strong> TPO agonists are for <strong>planned elective procedures</strong>, not rescue therapy.  
- <strong>Paracentesis in AKI:</strong> The <strong>5-L threshold</strong> is a trigger for albumin, not a hard stopping point.  
- <strong>PVT and refractory HE:</strong> Treat recent significant PVT with anticoagulation when appropriate; refractory encephalopathy may reflect a <strong>spontaneous shunt</strong> or <strong>TIPS-related</strong> issue.  
- <strong>MASLD and alcohol:</strong> Use fibrosis risk stratification for suspected MASLD, and remember there is <strong>no safe level of alcohol</strong> for health or cancer risk.

Meta Tag

Concept Acute Liver Failure

Concept Acute-on-Chronic Liver Failure

Concept Cirrhosis Complication

Concept Liver Transplant Evaluation

Concept Spontaneous Bacterial Peritonitis

Concept Portal Hypertension

Concept Hepatorenal Syndrome-Acute Kidney Injury

Concept Variceal Bleeding

Keywords

acute liver failure

acute-on-chronic liver failure

N-acetylcysteine

transplant referral

SBP prophylaxis

albumin

portal hypertension

carvedilol

HRS-AKI

variceal bleeding

albumin therapy

hepatorenal syndrome aki

Acute Liver Failure

Acute-on-Chronic Liver Failure

Cirrhosis Complication

Liver Transplant Evaluation

Spontaneous Bacterial Peritonitis

Portal Hypertension

Hepatorenal Syndrome-Acute Kidney Injury

Variceal Bleeding